[Skip to Content]
[Skip to Content Landing]
Other Articles
June 30, 1945

THROMBOCYTOPENIC PURPURA DUE TO MAPHARSEN (OXOPHENARSINE HYDROCHLORIDE.U. S. P.)

Author Affiliations

Detroit

From the Department of Medicine of Wayne University College of Medicine and City of Detroit Receiving Hospital.

JAMA. 1945;128(9):657-659. doi:10.1001/jama.1945.92860260002010a
Abstract

Blood dyscrasias such as thrombocytopenic purpura are uncommon complications of arsenotherapy for syphilis. It was nine years after the introduction of arsphenamine before Labbé and Langlois1 called attention to the fact that purpuric manifestations might be a complication of this therapy for syphilis.

Loveman2 was able to find reports of 14 instances of purpura hemorrhagica following arsphenamine therapy up to 1931 and added 1 case of his own. In 1942 Engelhardt,3 in reporting a case of purpura hemorrhagica following neoarsphenamine, found 50 cases of thrombopenic purpura complicating arsphenamine therapy. Falconer and Epstein,4 in discussing their observations on 8 cases of typical purpura following arsphenamine, have expressed the opinion that this toxic manifestation of arsphenamine therapy was relatively more frequent than reported and that the increased number of reported cases was probably due to a more widespread interest and alertness in recognition of complications due to arsphenamine therapy.

First Page Preview View Large
First page PDF preview
First page PDF preview
×